Ladenburg Thalmann Financial Services’s Phio Pharmaceuticals PHIO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Hold	0	–	–	–	5172
2017 Q4	–	Hold	0	–	–	–	5093
2017 Q3	–	Hold	0	–	–	–	4994
2017 Q2	–	Hold	0	–	–	–	4940
2017 Q1	–	Hold	0	–	–	–	4935
2016 Q4	–	Hold	0	–	–	–	4927
2016 Q3	–	Hold	0	–	–	–	4841
2016 Q2	–	Hold	0	–	–	–	4811
2016 Q1	–	Hold	0	–	–	–	4768
2015 Q4	–	Hold	0	–	–	–	4753
2015 Q3	–	Hold	0	–	–	–	4693
2015 Q2	–	Hold	0	–	–	–	4728
2015 Q1	–	Hold	0	–	–	–	4436
2014 Q4	–	Hold	0	–	–	–	4225
2014 Q3	–	Hold	0	–	–	–	4002
2014 Q2	–	Hold	0	–	–	–	3776
2014 Q1	–	Hold	0	–	–	–	3525

Other funds holding PHIO

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return